Charles Schwab Investment Management Inc. Acquires 3,783 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Charles Schwab Investment Management Inc. grew its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 1.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 205,376 shares of the business services provider's stock after purchasing an additional 3,783 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.16% of Huron Consulting Group worth $25,520,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HURN. Natixis Advisors LLC boosted its position in Huron Consulting Group by 32.7% during the third quarter. Natixis Advisors LLC now owns 18,571 shares of the business services provider's stock worth $2,019,000 after purchasing an additional 4,576 shares during the period. Quest Partners LLC boosted its position in shares of Huron Consulting Group by 131.9% in the third quarter. Quest Partners LLC now owns 13,814 shares of the business services provider's stock valued at $1,502,000 after acquiring an additional 7,858 shares during the period. Jennison Associates LLC boosted its position in shares of Huron Consulting Group by 5.7% in the third quarter. Jennison Associates LLC now owns 574,006 shares of the business services provider's stock valued at $62,394,000 after acquiring an additional 31,123 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Huron Consulting Group in the third quarter valued at approximately $457,000. Finally, Intech Investment Management LLC bought a new position in shares of Huron Consulting Group in the third quarter valued at approximately $328,000. Institutional investors own 93.90% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms have recently commented on HURN. Benchmark raised their price objective on shares of Huron Consulting Group from $140.00 to $165.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Wedbush began coverage on shares of Huron Consulting Group in a research note on Monday, February 3rd. They issued an "outperform" rating on the stock. Barrington Research raised their target price on shares of Huron Consulting Group from $142.00 to $167.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. William Blair reaffirmed an "outperform" rating on shares of Huron Consulting Group in a research note on Monday, March 10th. Finally, Truist Financial raised their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a research note on Tuesday, March 4th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $155.50.

Insider Buying and Selling

In related news, Director John Mccartney sold 500 shares of Huron Consulting Group stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.65, for a total value of $62,325.00. Following the transaction, the director now directly owns 56,688 shares of the company's stock, valued at $7,066,159.20. The trade was a 0.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director James H. Roth sold 2,000 shares of Huron Consulting Group stock in a transaction on Wednesday, January 8th. The stock was sold at an average price of $123.69, for a total transaction of $247,380.00. Following the completion of the transaction, the director now directly owns 50,534 shares in the company, valued at approximately $6,250,550.46. The trade was a 3.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 72,140 shares of company stock valued at $10,492,517 over the last three months. 2.02% of the stock is owned by company insiders.

Huron Consulting Group Price Performance

Shares of HURN stock traded down $7.68 during trading hours on Friday, hitting $140.87. 511,435 shares of the company's stock were exchanged, compared to its average volume of 123,255. The company has a market capitalization of $2.49 billion, a PE ratio of 30.62 and a beta of 0.53. Huron Consulting Group Inc. has a 12-month low of $84.26 and a 12-month high of $153.85. The business's 50 day simple moving average is $134.50 and its 200-day simple moving average is $122.33. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, topping the consensus estimate of $1.52 by $0.38. The firm had revenue of $399.31 million for the quarter, compared to the consensus estimate of $380.62 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. On average, equities research analysts anticipate that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.